WCG
EW icon

Weaver Consulting Group’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.63M Sell
46,379
-206
-0.4% -$16.1K 1% 28
2025
Q1
$3.38M Sell
46,585
-350
-0.7% -$25.4K 1.02% 24
2024
Q4
$3.47M Sell
46,935
-558
-1% -$41.3K 1.07% 23
2024
Q3
$3.13M Sell
47,493
-359
-0.8% -$23.7K 1% 26
2024
Q2
$4.42M Buy
47,852
+8,400
+21% +$776K 1.54% 15
2024
Q1
$3.77M Sell
39,452
-1,000
-2% -$95.6K 1.4% 17
2023
Q4
$3.08M Sell
40,452
-2,185
-5% -$167K 1.25% 20
2023
Q3
$2.95M Buy
42,637
+1,524
+4% +$106K 1.33% 18
2023
Q2
$3.88M Sell
41,113
-2
-0% -$189 1.71% 13
2023
Q1
$3.4M Sell
41,115
-1
-0% -$83 1.56% 14
2022
Q4
$3.07M Buy
41,116
+1,566
+4% +$117K 1.57% 13
2022
Q3
$3.27M Buy
39,550
+76
+0.2% +$6.28K 1.88% 12
2022
Q2
$3.75M Buy
39,474
+549
+1% +$52.2K 2.1% 10
2022
Q1
$4.58M Buy
38,925
+200
+0.5% +$23.5K 2.22% 10
2021
Q4
$5.02M Buy
38,725
+3
+0% +$389 2.42% 10
2021
Q3
$4.38M Buy
38,722
+118
+0.3% +$13.4K 2.38% 9
2021
Q2
$4M Buy
38,604
+780
+2% +$80.8K 2.25% 9
2021
Q1
$3.16M Buy
37,824
+1,494
+4% +$125K 1.94% 12
2020
Q4
$3.31M Buy
36,330
+675
+2% +$61.6K 2.07% 11
2020
Q3
$2.85M Buy
35,655
+1,575
+5% +$126K 1.64% 11
2020
Q2
$2.36M Sell
34,080
-663
-2% -$45.8K 1.37% 16
2020
Q1
$2.18M Buy
34,743
+639
+2% +$40.2K 1.43% 14
2019
Q4
$2.5M Buy
34,104
+1,365
+4% +$100K 1.34% 17
2019
Q3
$2.37M Hold
32,739
1.25% 19
2019
Q2
$2.02M Sell
32,739
-390
-1% -$24K 1.1% 19
2019
Q1
$2.05M Buy
+33,129
New +$2.05M 0.58% 28